Franziska Michalski

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series.

Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series.

Journal: The Lancet. Haematology

Published: June 02, 2016

Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting.

Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting.

Journal: Thrombosis and haemostasis

Published: April 18, 2016

Vaginal bleeding and heavy menstrual bleeding during direct oral anti-Xa inhibitor therapy.

Vaginal bleeding and heavy menstrual bleeding during direct oral anti-Xa inhibitor therapy.

Journal: Thrombosis and haemostasis

Published: November 24, 2015

Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.

Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.

Journal: Thrombosis and haemostasis

Published: October 30, 2015

Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.

Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.

Journal: Thrombosis and haemostasis

Published: February 10, 2015

Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.

Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.

Journal: Thrombosis and haemostasis

Published: November 18, 2014

Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registry.

Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registry.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: September 18, 2014

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry.

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry.

Journal: Blood

Published: May 27, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026